Rubraca

Indicated For

ovarian cancer, prostate cancer

About This Medication

# Rubraca Patient Assistance Program (PAP) Patient Guide: How to Get Rubraca at Low or No Cost Rubraca (rucaparib) is a prescription medication used to treat certain types of advanced ovarian cancer and prostate cancer in adults. This guide explains the **Patient Assistance Program (PAP)** from pharma&, which provides Rubraca at no cost to eligible uninsured patients or those with insurance denials who meet income limits.[1][3] ## About Rubraca **Rubraca** is a targeted therapy called a PARP inhibitor. It works by blocking enzymes that cancer cells use to repair their DNA, helping to slow or stop cancer growth. It is FDA-approved for: - **Maintenance treatment** of recurrent ovarian, fallopian tube, or primary peritoneal cancer in adults with certain genetic changes (like BRCA mutations), often after chemotherapy response.[1][5][6] - Treatment of advanced ovarian cancer after two or more chemotherapy treatments.[6] - Prostate cancer with specific DNA repair gene changes (HRD-positive), after other treatments like chemotherapy or other PARP inhibitors.[6] Rubraca is taken as oral tablets, usually 600 mg twice daily, with or without food. Your doctor will adjust the dose based on side effects like low blood counts, nausea, or fatigue. Do not start until recovered from prior chemotherapy toxicities. Monthly blood tests are needed to monitor for cytopenias (low blood cells).[3][6] Without help, a one-month supply costs tens of thousands of dollars due to patent protection until 2035—no generics yet.[1] ## Who Qualifies for the Rubraca PAP? The PAP is for patients who **cannot afford Rubraca** and meet these criteria: - Uninsured **or** insured but denied coverage (provide proof of denial).[1][3] - **Not eligible** if on Medicare, Medicaid, or other government insurance.[1][3] - Meet **income limits** (exact household size thresholds not publicly specified; subject to audit).[3] - Prescription must be **on-label** (FDA-approved use); off-label prescriptions do not qualify.[3][6] - Receiving treatment from a licensed prescriber who confirms appropriateness.[3] **Note**: Income limits apply based on Federal Poverty Level (FPL) or similar guidelines, but specifics like 400% FPL are not detailed—call (844) 779-7707 to verify your eligibility.[1][3] ## Income Eligibility Breakdown Specific dollar thresholds vary by household size and are subject to change. Programs like this often use 400-500% of FPL, but Rubraca PAP requires verification. Here's a general example based on 2026 FPL estimates (confirm with program): | Household Size | Estimated Max Annual Income (e.g., ~400% FPL) | Notes | |---------------|----------------------------------------------|-------| | 1 (Individual) | ~$60,000 | Subject to audit[3] | | 2 (Couple) | ~$81,000 | Varies by location[1] | | 3 | ~$102,000 | Proof required[3] | | 4 | ~$123,000 | Larger families higher[2] | **Always call (844) 779-7707** for your exact eligibility, as limits are not fixed publicly and depend on audits.[1][3] Services like Prescription Hope suggest up to $50K individual/$70K household, but that's a third-party option.[2] ## Insurance Requirements - **Uninsured**: Eligible if income-qualified.[1][3] - **Insured**: Must submit **proof of denial**; program cannot bill insurance or count toward deductibles.[1][3] - **Excluded**: Medicare Part D, Medicaid, VA, Tricare, or other government programs. Medicare patients: Apply for **Extra Help (Low-Income Subsidy)** via SSA.gov—may reduce costs to ~$11.[1] Insurance may require **prior authorization** or step therapy (e.g., try Lynparza or Zejula first).[4][5][8] ## Step-by-Step Application Process 1. **Talk to your doctor**: Confirm Rubraca is right for you (on-label). They complete the **Enrollment and Comprehensive Support Form**.[3] 2. **Gather documents**: - Proof of income (tax returns, pay stubs, etc.).[3] - Proof of insurance denial (if insured).[1][3] - Valid **prescription** for Rubraca.[3] - **Completed enrollment form** (patient consent for PHI sharing).[3] 3. **Apply**: Multiple methods—call **(844) 779-7707** or use Rubraca Access Support via AssistRx. Doctor helps submit.[1][3] 4. **Sign consents**: Authorize sharing health info with pharma& for program admin.[3] 5. **Wait for approval**: 2-4 weeks processing.[2][3] ## Timeline and Delivery - **Processing**: Typically **2-4 weeks** after all documents received.[2] - **Delivery**: Shipped free to your **home** or **prescriber's office**.[3] - **Reauthorization**: **Required** periodically—doctor renews; track refills.[3] ## Other Rubraca Support Options If PAP denies you: - **Co-pay Assistance**: $0 copay for commercial insurance (not government).[1] - **QuickStart**: Free 15-day supply (up to 60 days) for coverage delays, any income.[1][3] - **Coverage Link**: Up to 90 days free during insurance changes.[1][3] - **Prescription Hope**: $60-70/month flat fee, income up to $50K individual.[2] - **Extra Help** for Medicare.[1] No biosimilars; alternatives like Lynparza/Zejula may be required by insurance first.[4][5] ## If Denied: Next Steps - Appeal with more docs or try other programs above.[1] - Contact Rubraca support at (844) 779-7707.[1][3] - Explore state aid, generics (none yet), or compassionate use. ## Disclaimer This guide is for informational purposes only and based on available program details as of 2026. Eligibility, terms, and income limits can change—**always verify directly with pharma& at (844) 779-7707**. Not medical advice; consult your doctor. pharma& or agents may audit applications. Off-label use ineligible.[1][3][6] (Word count: 1028)

Program information last verified: March 25, 2026